Therapies that target the utilization of fat by tumors and activate a type of cell death dependent on fat molecules may be a ...

A new multi-pronged antibody design could help immune cells receive stronger activation signals against cancer. Researchers ...

KAIST researchers have developed a way to reprogram immune cells already inside tumors into cancer-killing machines. A drug ...

A research team led by Professor Chen Peng from the College of Chemistry and Molecular Engineering at Peking University has ...

Your dermatologist or oncologist may have told you what type of advanced squamous cell carcinoma you have. Here’s what each type means: Locally advanced squamous cell carcinoma: This means cancer has ...

A recent publication in Nature Medicine describes a novel immunotherapy targeting pancreatic cancer that has shown promising ...

A shift in the balance between two lipids – cholesterol and sphingomyelin – makes hybrid epithelial-mesenchymal cancer cells less responsive to certain chemotherapy drugs.

The Korea Advanced Institute of Science and Technology (KAIST) researchers have developed a way to reprogram immune cells already inside tumours into cancer-killing machines. A drug injected directly ...

Researchers have developed a new class of antibodies that amplify the immune system’s ability to fight cancer. By clustering ...

Therapies that target the utilization of fat by tumors and activate a type of cell death dependent on fat molecules may be a ...

A recent publication in Nature Medicine describes a novel immunotherapy targeting pancreatic cancer that has shown promising ...

Researchers found in mice that multiple nutrients and cancer cell characteristics work together to control the spread of ...